Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-19

Clinical Trial Update: Ketamine Use in Electroconvulsive Therapy [NA]

View source ↗

Summary

This clinical trial update indicates that the study evaluating ketamine use during electroconvulsive therapy for depression has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Depression | NA | Status: WITHDRAWN